应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
OBX Obsidian Therapeutics Inc
盘前交易 08-24 08:11:35 EDT
19.90
-0.29
-1.44%
最高
21.33
最低
18.44
成交量
144.93万
今开
20.47
昨收
20.19
日振幅
14.31%
总市值
12.28亿
流通市值
11.83亿
总股本
6,173万
成交额
2,914万
换手率
2.44%
流通股本
5,946万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Obsidian Therapeutics宣布:晚期黑色素瘤新药Amsoki-Cel (Obx-115) 关键注册队列首例患者成功入组
美股速递 · 08-05
Obsidian Therapeutics宣布:晚期黑色素瘤新药Amsoki-Cel (Obx-115) 关键注册队列首例患者成功入组
加载更多
公司概况
公司名称:
Obsidian Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Obsidian Therapeutics, Inc.是一家于2026年4月10日在特拉华州注册成立的生物制药公司。该公司专注于开发小分子超氧化物歧化酶(SOD)模拟物,旨在通过减少副作用来改善癌症放射治疗的效果。Obsidian目前的产品组合包括一种泛NOS抑制剂,其主要研发项目正处于乳腺癌联合治疗的I/II期临床试验阶段。该公司还开发用于治疗实体瘤的工程化肿瘤浸润淋巴细胞(TIL)疗法。Obsidian的专有cytoDRiVE平台能够通过药物响应结构域控制蛋白质功能,初期重点开发基于该平台的TIL细胞疗法。Obsidian的主要候选产品是一种新型的基因工程自体TIL细胞疗法,目前正在进行治疗晚期黑色素瘤和非小细胞肺癌的临床试验。
发行价格:
--
{"stockData":{"symbol":"OBX","market":"US","secType":"STK","nameCN":"Obsidian Therapeutics Inc","latestPrice":19.9,"timestamp":1787342400000,"preClose":20.19,"halted":0,"volume":1449276,"delay":0,"changeRate":-0.014363546310054615,"floatShares":59462058,"shares":61727211,"eps":-1287.1293,"marketStatus":"盘前交易","change":-0.29,"latestTime":"08-24 08:11:35 EDT","open":20.47,"high":21.33,"low":18.44,"amount":29139188,"amplitude":0.14314,"askPrice":23,"askSize":500,"bidPrice":19.9,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1287.1293,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":19.9,"postHourTrading":{"tag":"盘后","latestPrice":19.9,"preClose":19.9,"latestTime":"16:10 EDT","volume":63,"amount":1260.38,"timestamp":1787343004329,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":25.277246844626724},"requestUrl":"/m/hq/s/OBX","defaultTab":"news","newsList":[{"id":"1160444967","title":"Obsidian Therapeutics宣布:晚期黑色素瘤新药Amsoki-Cel (Obx-115) 关键注册队列首例患者成功入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1160444967","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160444967?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:06","pubTimestamp":1785927982,"startTime":"0","endTime":"0","summary":"Obsidian Therapeutics公司今日重磅宣布,其针对晚期黑色素瘤的细胞疗法——Amsoki-Cel(原名Obx-115),在1/2期Agni-01研究的注册导向队列中,已成功完成首例患者入组。这一里程碑事件,标志着该创新疗法正式迈入关键性临床开发阶段,为全球黑色素瘤患者带来了全新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.obsidiantx.com","stockEarnings":[{"period":"1week","weight":0.1199},{"period":"1month","weight":-0.6018},{"period":"ytd","weight":-0.6018}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Obsidian Therapeutics, Inc.是一家于2026年4月10日在特拉华州注册成立的生物制药公司。该公司专注于开发小分子超氧化物歧化酶(SOD)模拟物,旨在通过减少副作用来改善癌症放射治疗的效果。Obsidian目前的产品组合包括一种泛NOS抑制剂,其主要研发项目正处于乳腺癌联合治疗的I/II期临床试验阶段。该公司还开发用于治疗实体瘤的工程化肿瘤浸润淋巴细胞(TIL)疗法。Obsidian的专有cytoDRiVE平台能够通过药物响应结构域控制蛋白质功能,初期重点开发基于该平台的TIL细胞疗法。Obsidian的主要候选产品是一种新型的基因工程自体TIL细胞疗法,目前正在进行治疗晚期黑色素瘤和非小细胞肺癌的临床试验。","exchange":"NASDAQ","name":"Obsidian Therapeutics Inc","nameEN":"Obsidian Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Obsidian Therapeutics Inc(OBX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Obsidian Therapeutics Inc(OBX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Obsidian Therapeutics Inc,OBX,Obsidian Therapeutics Inc股票,Obsidian Therapeutics Inc股票老虎,Obsidian Therapeutics Inc股票老虎国际,Obsidian Therapeutics Inc行情,Obsidian Therapeutics Inc股票行情,Obsidian Therapeutics Inc股价,Obsidian Therapeutics Inc股市,Obsidian Therapeutics Inc股票价格,Obsidian Therapeutics Inc股票交易,Obsidian Therapeutics Inc股票购买,Obsidian Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Obsidian Therapeutics Inc(OBX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Obsidian Therapeutics Inc(OBX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}